- About
- Advertise
- CureToday.com
- OncLive.com
- OncNursingNews.com
- TargetedOnc.com
- Contact
- Terms and Conditions
- Privacy
- Do Not Sell My Personal Information
© 2023 MJH Life Sciences™ and Cancer Network. All rights reserved.
Nataliya V. Uboha, MD, PhD | Authors
A Pilot Study of Omalizumab to Treat Oxaliplatin-Induced Hypersensitivity Reaction
July 18, 2022
Stacy Stein, MD, and co-investigators, research omalizumab to treat oxaliplatin hypersensitivity reactions for patients with gastrointestinal cancers.
Advertisement
Advertisement